StockVS

NASDAQ · Medical Care Facilities · USD

Option Care Health, Inc. (OPCH) Stock Analysis

Option Care Health, Inc. (OPCH) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

OPCH

$24.21

−$0.25 (−1.02%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare OPCH with… →

OPCH Key Statistics

As of Sep 4, 2026
Trading
Open
$24.39
Previous Close
$24.46
Day's Range
24.10–24.40
52-Week Range
18.01–36.80
Volume
1.16M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.61
Valuation
Market Cap
$3.63B
P/E Ratio
18.34
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
11.63
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
1.18
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.64
EPS (ttm)Profit attributable to each share over the last twelve months.
1.32
Financials (FY)
Revenue (FY)
$5.65B+13.03%
Net Income (FY)
$207.59M−2.00%
Profit marginThe share of revenue left as profit after all costs and taxes.
3.68%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
149.79M
1-Year Return
−15.88%
Dividend and dates
Earnings Date
October 29, 2026estimated
Avg Volume
2.45M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

OPCH Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−24.01%
2025+37.33%
2024−31.14%
2023+11.96%
2022+5.80%
2021+81.84%
2020+4.83%
2019+4.48%
2018+22.68%
2017+179.81%
2016 (partial year)−60.75%

As of September 4, 2026.

OPCH Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$5.65B$207.59M3.7%
2024$5.00B$211.82M4.2%
2023$4.30B$267.09M6.2%
2022$3.94B$150.56M3.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$5.65B$1.09B$337.91M$207.59M3.7%
2024$5.00B$1.01B$321.83M$211.82M4.2%
2023$4.30B$981.22M$314.60M$267.09M6.2%
2022$3.94B$866.92M$240.23M$150.56M3.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

OPCH Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricOPCHMedical Care Facilities medianvs median
P/E18.3419.848% below
P/S ratio0.640.9533% below
Profit margin3.68%3.06%0.6 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Option Care Health, Inc. (OPCH) is capitalised at $3.63B on the latest close. It is classified in the Medical Care Facilities industry, within the Healthcare sector. Headcount on file is 8,000.

The most recent close on file for OPCH is $24.21, dated September 4, 2026. That is −$0.25 (−1.02%) against the previous close. Over the past 52 weeks the price has ranged from $18.01 to $36.80. The latest close sits 34.43% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $5.65B. Against the prior fiscal year total of $5.00B, that is a change of +13.03%. Net income for the same year was $207.59M. That is −2.00% against the prior fiscal year. Profit margin runs at 3.68%. That is 0.6 percentage points above the Medical Care Facilities median of 3.06%. Earnings per share on a trailing basis come to 1.32.

Across the 4 fiscal years on file, revenue moves from $3.94B in 2022 to $5.65B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

OPCH trades at a trailing price-to-earnings ratio of 18.34. That is 7.56% below the Medical Care Facilities median of 19.84. The forward P/E on file is 11.63. The PEG ratio, which sets the P/E against expected earnings growth, reads 1.18. Measured against sales, the shares trade at 0.64 times revenue. On price-to-sales that is 32.99% below the Medical Care Facilities median of 0.95. The medians here are taken across 57 Medical Care Facilities companies that report the metric.

Beta against the wider market is reported at 0.61. Daily returns over the trailing 10 years annualize to a volatility of 55.12%. The trailing one-year price return is −15.88%. Measured over 10 years, that is +8.65% a year compounded.

Growth & Income

The record shows no dividend for OPCH.

So far in 2026 the price is −24.01%. The strongest complete calendar year on file is 2017 at +179.81%; the weakest is 2024 at −31.14%. Of the 9 complete calendar years on file, 8 finished higher.

Peer Comparison

Option Care Health, Inc. (OPCH) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Option Care Health, Inc. OPCH $3.63B 18.3
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. Option Care Health, Inc. trades at a P/E of 18.3.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

View all Medical Care Facilities stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Visit website →